Literature DB >> 26152642

Neuronal SH-SY5Y cells use the C-dystrophin promoter coupled with exon 78 skipping and display multiple patterns of alternative splicing including two intronic insertion events.

Atsushi Nishida1, Maki Minegishi, Atsuko Takeuchi, Hiroyuki Awano, Emma Tabe Eko Niba, Masafumi Matsuo.   

Abstract

Duchenne muscular dystrophy (DMD) is a progressive muscle wasting disease caused by mutations in the dystrophin gene. One-third of DMD cases are complicated by mental retardation. Here, we used reverse transcription PCR to analyze the pattern of dystrophin transcripts in neuronal SH-SY5Y cells. Among the three alternative promoters/first exons at the 5'-end, only transcripts containing the brain cortex-specific C1 exon could be amplified. The C-transcript appeared as two products: a major product of the expected size and a minor larger product that contained the cryptic exon 1a between exons C1 and 2. At the 3'-end there was complete exon 78 skipping. Together, these findings indicate that SH-SY5Y cells have neuron-specific characteristics with regard to both promoter activation and alternative splicing. We also revealed partial skipping of exons 9 and 71. Four amplified products were obtained from a fragment covering exons 36-41: a strong expected product, two weak products lacking either exon 37 or exon 38, and a second strong larger product with a 568-bp insertion between exons 40 and 41. The inserted sequence matched the 3'-end of intron 40 perfectly. We concluded that a cryptic splice site was activated in SH-SY5Y cells to create the novel, unusually large, exon 41e (751 bp). In total, we identified seven alternative splicing events in neuronal SH-SY5Y cells, and calculated that 32 dystrophin transcripts could be produced. Our results may provide clues in the analysis of transcriptype-phenotype correlations as regards mental retardation in DMD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26152642     DOI: 10.1007/s00439-015-1581-2

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  52 in total

Review 1.  Understanding alternative splicing: towards a cellular code.

Authors:  Arianne J Matlin; Francis Clark; Christopher W J Smith
Journal:  Nat Rev Mol Cell Biol       Date:  2005-05       Impact factor: 94.444

Review 2.  Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.

Authors:  Lulzim Shkreta; Brendan Bell; Timothée Revil; Julian P Venables; Panagiotis Prinos; Sherif Abou Elela; Benoit Chabot
Journal:  Cancer Treat Res       Date:  2013

3.  Specific expression of G-dystrophin (Dp71) in the brain.

Authors:  D C Górecki; E A Barnard
Journal:  Neuroreport       Date:  1995-04-19       Impact factor: 1.837

4.  Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression.

Authors:  Fatma Daoud; Nathalie Angeard; Bénédicte Demerre; Itxaso Martie; Rabah Benyaou; France Leturcq; Mireille Cossée; Nathalie Deburgrave; Yoann Saillour; Sylvie Tuffery; Andoni Urtizberea; Annick Toutain; Bernard Echenne; Martine Frischman; Michèle Mayer; Isabelle Desguerre; Brigitte Estournet; Christian Réveillère; Jean Marie Cuisset; Jean Claude Kaplan; Delphine Héron; François Rivier; Jamel Chelly
Journal:  Hum Mol Genet       Date:  2009-07-14       Impact factor: 6.150

5.  Six novel transcripts that remove a huge intron ranging from 250 to 800 kb are produced by alternative splicing of the 5' region of the dystrophin gene in human skeletal muscle.

Authors:  A Surono; Y Takeshima; T Wibawa; Z A Pramono; M Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1997-10-29       Impact factor: 3.575

6.  Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus.

Authors:  C A Feener; M Koenig; L M Kunkel
Journal:  Nature       Date:  1989-04-06       Impact factor: 49.962

7.  A novel dystrophin isoform is required for normal retinal electrophysiology.

Authors:  V N D'Souza; T M Nguyen; G E Morris; W Karges; D A Pillers; P N Ray
Journal:  Hum Mol Genet       Date:  1995-05       Impact factor: 6.150

8.  Dystrophin is a tumor suppressor in human cancers with myogenic programs.

Authors:  Yuexiang Wang; Adrian Marino-Enriquez; Richard R Bennett; Meijun Zhu; Yiping Shen; Grant Eilers; Jen-Chieh Lee; Joern Henze; Benjamin S Fletcher; Zhizhan Gu; Edward A Fox; Cristina R Antonescu; Christopher D M Fletcher; Xiangqian Guo; Chandrajit P Raut; George D Demetri; Matt van de Rijn; Tamas Ordog; Louis M Kunkel; Jonathan A Fletcher
Journal:  Nat Genet       Date:  2014-05-04       Impact factor: 38.330

9.  Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines.

Authors:  John C Castle; Chaolin Zhang; Jyoti K Shah; Amit V Kulkarni; Auinash Kalsotra; Thomas A Cooper; Jason M Johnson
Journal:  Nat Genet       Date:  2008-11-02       Impact factor: 38.330

Review 10.  Long non-coding RNA-dependent transcriptional regulation in neuronal development and disease.

Authors:  Brian S Clark; Seth Blackshaw
Journal:  Front Genet       Date:  2014-06-06       Impact factor: 4.599

View more
  11 in total

1.  HEK293 cells express dystrophin Dp71 with nucleus-specific localization of Dp71ab.

Authors:  Atsushi Nishida; Sato Yasuno; Atsuko Takeuchi; Hiroyuki Awano; Tomoko Lee; Emma Tabe Eko Niba; Takahiro Fujimoto; Kyoko Itoh; Yasuhiro Takeshima; Hisahide Nishio; Masafumi Matsuo
Journal:  Histochem Cell Biol       Date:  2016-04-25       Impact factor: 4.304

Review 2.  Normal and altered pre-mRNA processing in the DMD gene.

Authors:  Sylvie Tuffery-Giraud; Julie Miro; Michel Koenig; Mireille Claustres
Journal:  Hum Genet       Date:  2017-06-09       Impact factor: 4.132

3.  Cryptic splice activation but not exon skipping is observed in minigene assays of dystrophin c.9361+1G>A mutation identified by NGS.

Authors:  Emma Tabe Eko Niba; Atsushi Nishida; Van Khanh Tran; Dung Chi Vu; Masaaki Matsumoto; Hiroyuki Awano; Tomoko Lee; Yasuhiro Takeshima; Hisahide Nishio; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2017-01-19       Impact factor: 3.172

Review 4.  The Duchenne muscular dystrophy gene and cancer.

Authors:  Leanne Jones; Michael Naidoo; Lee R Machado; Karen Anthony
Journal:  Cell Oncol (Dordr)       Date:  2020-11-14       Impact factor: 6.730

5.  Targeted RNA-Seq profiling of splicing pattern in the DMD gene: exons are mostly constitutively spliced in human skeletal muscle.

Authors:  Anne-Laure Bougé; Eva Murauer; Emmanuelle Beyne; Julie Miro; Jessica Varilh; Magali Taulan; Michel Koenig; Mireille Claustres; Sylvie Tuffery-Giraud
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

6.  Nova1 mediates resistance of rat pheochromocytoma cells to hypoxia-induced apoptosis via the Bax/Bcl-2/caspase-3 pathway.

Authors:  Hualing Li; Bei Lv; Ling Kong; Jing Xia; Ming Zhu; Lijuan Hu; Danyang Zhen; Yifan Wu; Xiaoqin Jia; Sujuan Zhu; Hengmi Cui
Journal:  Int J Mol Med       Date:  2017-08-03       Impact factor: 4.101

7.  DMD transcripts in CRL-2061 rhabdomyosarcoma cells show high levels of intron retention by intron-specific PCR amplification.

Authors:  Emma Tabe Eko Niba; Ryo Yamanaka; Abdul Qawee Mahyoob Rani; Hiroyuki Awano; Masaaki Matsumoto; Hisahide Nishio; Masafumi Matsuo
Journal:  Cancer Cell Int       Date:  2017-05-23       Impact factor: 5.722

8.  Intronic Alternative Polyadenylation in the Middle of the DMD Gene Produces Half-Size N-Terminal Dystrophin with a Potential Implication of ECG Abnormalities of DMD Patients.

Authors:  Abdul Qawee Mahyoob Rani; Tetsushi Yamamoto; Tatsuya Kawaguchi; Kazuhiro Maeta; Hiroyuki Awano; Hisahide Nishio; Masafumi Matsuo
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

9.  Detection of Dystrophin Dp71 in Human Skeletal Muscle Using an Automated Capillary Western Assay System.

Authors:  Tatsuya Kawaguchi; Emma Tabe Eko Niba; Abdul Qawee Mahyoob Rani; Yoshiyuki Onishi; Makoto Koizumi; Hiroyuki Awano; Masaaki Matsumoto; Masashi Nagai; Shinobu Yoshida; Sachiko Sakakibara; Naoyuki Maeda; Osamu Sato; Hisahide Nishio; Masafumi Matsuo
Journal:  Int J Mol Sci       Date:  2018-05-23       Impact factor: 5.923

10.  Schwann cell-specific Dp116 is expressed in glioblastoma cells, revealing two novel DMD gene splicing patterns.

Authors:  Abdul Qawee Mahyoob Rani; Kazuhiro Maeta; Tatsuya Kawaguchi; Hiroyuki Awano; Masashi Nagai; Hisahide Nishio; Masafumi Matsuo
Journal:  Biochem Biophys Rep       Date:  2019-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.